Ablation has substantial evidence base in the management of ventricular arrhythmia (VA). It can be a 'lifesaving' procedure in the acute setting of VA storm. Current reports on ablation in VA storm are in the form of small series and have relative small representation in a large observational series. The purpose of this study was to systematically synthesize the available literature to appreciate the efficacy and safety of ablation in the setting of VA storm. The medical electronic databases through 31 January 2012 were searched. Ventricular arrhythmia storm was defined as recurrent (≥3 episodes or defibrillator therapies in 24 h) or incessant (continuous .12 h) VA. Studies reporting data on VA storm patients at the individual or study level were included. A total of 471 VA storm patients from 39 publications were collated for the analysis. All VAs were successfully ablated in 72% [95% confidence interval (CI) 71-89%] and 9% (95% CI: 3-10%) had a failed procedure. Procedure-related mortality occurred in three patients (0.6%). Only 6% patients had a recurrence of VA storm. The recurrence of VA was significantly higher after ablation for arrhythmic storm of monomorphic ventricular tachycardia (VT) relative to ventricular fibrillation or polymorphic VT with underlying cardiomyopathy (odds ratio 3.76; 95% CI: 1.65-8.57; P ¼ 0.002). During the follow-up (61 + 37 weeks), 17% of patients died (heart failure 62%, arrhythmias 23%, and non-cardiac 15%) with 55% deaths occurring within 12 weeks of intervention. The odds of death were four times higher after a failed procedure compared with those with a successful procedure (95% CI: 2.04-8.01, P , 0.001). Ventricular arrhythmia storm ablation has high-acute success rates, with a low rate of recurrent storms. Heart failure is the dominant cause of death in the long term. Failure of the acute procedure carries a high mortality.
Introduction
Ventricular arrhythmia (VA) storm is increasingly being recognized as a distinctive arrhythmia syndrome with its specific management issues and prognostic consequences that differ from ventricular tachycardia (VT) and ventricular fibrillation (VF) episodes unrelated to storm.
1,2 Implantable cardioverter defibrillator (ICD) is recommended as primary or secondary prevention of sudden death in patients with cardiomyopathy and life-threatening genetic cardiac disorders. 3 -6 However, despite the presence of an ICD, the appearance of a VA storm still portends a high mortality. 2,7 -9 The AVID study which followed secondary prevention ICD recipients observed a 5.6-fold relative increase in mortality in the first 12 weeks following the development of VA storm and 2.4-fold over 3 years when compared with those who had VA episodes unrelated to storm. 2 Indeed every defibrillator shock therapy multiplies the mortality risk 10, 11 and the impact of multiple therapies over a short period can have unpredictable consequences. Radiofrequency catheter ablation (RFA) is evolving as the standard care in patients with VA storm, with VT-free long-term survival improved with early invasive intervention. 12 Other approaches, such as transcoronary ethanol ablation, generally, remain as a treatment of last resort after a failure of RFA. 13 Most of the published data on VA storm ablation are single-centre small series or case reports and have relative small representation within large multicentre VT ablation series. 14, 15 Therefore, given the lack of large data, interpretability of reported information on survival outcomes † Previous presentation: Presented at the Annual Scientific Sessions of the Heart Rhythm Society, May 2012, Boston, USA and published in abstract form (Heart Rhythm. 2012;9:S357 -S388).
in VA storm management remains contentious. Despite this relatively modest supporting evidence, current guidelines endorse the role of catheter ablation for VA storm management with a consensus on early intervention. 1 We, therefore, undertook this systematic review to organize the published data on high-risk VA storm patients and examine the efficacy and safety of VA storm ablation.
Methods
The protocol for conducting this systematic review was made following the guidelines by NHS Centre for Reviews and Dissemination report. 16 All published case series documenting invasive electrophysiology data and follow-up on VA storm patients were sought. For the purpose of this review, the term VA storm was defined as (i) recurrent VA in a short time (≥3 separate episodes in 24 h, each requiring termination by intervention), (ii) frequent defibrillator therapies (≥3 separate episodes separated by 5 min in 24 h), or (iii) incessant VA (continuous VA that recurred promptly despite intervention for termination over .12 h).
1,3

Identification of research
The medical scientific electronic databases (MEDLINE, Web of Science, Science Direct, Cochrane Register, EMBASE) were comprehensively searched using the search terms 'ventricular tachycardia' or 'ventricular fibrillation' and 'ablation'. No limits of start date or language were applied. The search was conducted up through 31 January 2012. The retrieved data were then filtered for terms 'storm' or 'recurrent' or 'incessant' anywhere in the title or abstract.
Reference lists from the review articles were assessed for any other relevant publications missed in the search. The January 2012 issues of all major medical and electrophysiology journals were reviewed for latest articles not available on the databases. The studies from non-English journals were included if adequate information was available in the translated abstract or full text. 17 -19 As a study on invasive VA storm management is more likely to be published based on significance of the results, this bias arising in the published literature was minimized by including all published reports irrespective of the ranking of the journal citations. All single-case reports were excluded. Whenever publications were identified as parallel repetition of a patient series from the same author group, only one was selected on the merit of its quality.
Quality assessment and selection of studies
All studies retrieved after filtering were hand-searched in their full texts for data on VA storm patients. Table 1 gives the details of selection criteria applied for inclusion of a study. Authors with subject expertise (S.N., A.N.G.) and methodological expertise (A.G.B.) assessed inclusion of individual studies to minimize the uncertainty of study selection. No pre-specified criteria on the approach of invasive management were applied and no definition of procedural success was stipulated.
Data extraction
All demographic data on baseline characteristics, nature of VA, ablation or other intervention methodology, acute outcomes, complications, follow-up, recurrences, and mortality were extracted by two researchers independently (S.N., A.N.G.). Discrete data and events were recorded as total numbers (sex, underlying heart disease, nature of VA, type of intervention, procedural success, complication, number of procedures, VA recurrence, mortality) while continuous data were recorded either as a mean [age, ejection fraction (EF), VT cycle length] or a median value (follow-up duration, time of recurrence, time of death). For the purpose of assessing the effect of predictor variables such as age, EF, underlying heart disease, nature of VA, and procedural success on the incidence of outcomes of VA recurrence and mortality, individual patient demographic and survival data were retrieved whenever detailed in the study. Hazard ratio (HR), odds ratio (OR), and confidence intervals (CI) for predictor variables were extracted whenever individual data were not explicit. Studies where VA morphology was not specified it was assumed as monomorphic VT. Polymorphic VT (pVT) and VF were treated together for the purpose of analysis.
The primary outcome was all-cause mortality. Secondary outcomes assessed were cardiac mortality, VA recurrence, and VA storm recurrence. The VA recurrences were labelled as unspecified morphology if reported only as ICD therapies.
Data synthesis and statistical analysis
Descriptive data were reported as the mean and standard deviation (or median and range for skewed observations) for continuous variables and absolute frequencies with 95% CI for categorical variables. Heterogeneity in nature of VA, ablation methodology, and reporting of procedural result among studies was qualitatively described. Studies with more than five patients reporting individual level demographic predictor data (age and EF) and outcomes (time to recurrence of VA, time to death, recurrence of VA, death) were grouped for predictor analysis. The association between these predictors and outcomes within each study was analysed using Cox proportional hazards and logistic regression models. 
Results
Identification of literature
The elementary online database search on 'ventricular tachycardia' or 'ventricular fibrillation' and 'ablation' identified 3646 unique publications. After filtering these data in titles and abstract, 218 potential publications of VA storm were retained for secondary review. Out of these, 179 publications were excluded on general criteria as detailed in Figure 1 . Twelve of these excluded publications collectively reported ablation outcomes in 628 VA patients, but did not adequately provide separate breakdown of their 261 VA storm patients. 12 -15,20 -27 Finally, 39 publications were included for the purpose of this systematic review. The studies included in this analysis were all published after 1991, and had collectively reported data on 519 patients (range 2 -95, median 8). 17 -19,28 -63 Of these, 471 patients were with VA storm and their data were extracted for statistical analysis. 
Basic clinical and demographic data
Data of 39 publications with 471 patients were pooled together as study population. 
Procedural strategy
Ventricular arrhythmia storm-related instability and multiple cardioversions necessitated deep sedation with mechanical ventilation (13%), inotropic support (11%), intraaortic balloon counterpulsation (1.5%), extracorporeal membrane oxygenation (2%), or ventricular-assist device (0.4%) in 23% patients before or during an electrophysiological procedure. 62 These were mostly desperate measures after failure of medical therapy and radiofrequency ablation. However, few studies reported cases that were managed only with non-RFA invasive strategies due to severe instability, multiple, or non-mappable VTs 57 or pVT. 62, 63 Three papers published in the era before RFA became widely available described electrofulgration 33, 64 and ethanol ablation 28 as the primary treatment for incessant VT.
Non-radiofrequency catheter ablation methods
Catheter-based radiofrequency catheter ablation Catheter-based RFA was the primary mode of invasive management in 88% of patients. Among these, irrigated RFA was used in 65% of patients. The use of 3D mapping was cited in 21 publications after year 2003. Two publications 53, 56 tested the utility of magnetic navigation and irrigated tip catheter ablation in VA storm. Whereas 90% of patients underwent left or right ventricular endocardial mapping and ablation, a combined endo-epicardial approach was performed in 9% of patients due to arrhythmia recurrence after the first procedure. 18,38,40,48,55,59 -61,63 Three patients (1%) underwent only epicardial ablation because of the presence of an intraventricular thrombus.
38,40
Electrophysiologic characteristics
Scar-related re-entry was the commonest mechanism of VA storm seen in 83% of patients. Recurrent VA triggered by Purkinje-related or myocardial premature ventricular complexes (PVCs) was present in 14%. 
Procedural result
Definition of success Most of the studies reported results as complete success (no inducible VT), partial success (no inducible clinical VT), and failure (inducible clinical VT) based on formal induction at the end of the procedure. However, in some studies, including a few with catheterbased RFA, the inducibility of VA was not assessed and outcomes were reported as complete suppression of clinical VA, partial suppression of clinical arrhythmia or failure. 35,36,42,54,57,58,62 -64 One study reported success as elimination of scar-related electrograms. 43 None of these studies was excluded for the assessment of procedural success or failure as a predictor of mortality. One study that did not report acute procedural outcomes in adequate detail was excluded for this analysis.
18
Acute procedural result In the 447 patients, all VA were successfully ablated in 72% (95% CI: 71 -89%) with the clinical VA ablated in 91% (95% CI: 90 -97%). Multiple procedures, including more than one mode of intervention, were required in 91 (19%) patients resulting in average 1.3 + 0.4 procedures per patient. The clinical VA remained inducible in 9% patients (95% CI: 3-10%).
The procedure-related complication rate was low, with 10 (2%) patients having significant complications that included death (three patients, 0.6%, cause of deaths reported as myocardial infarction, pericardial tamponade, and electromechanical dissociation), stroke (three patients, 0.6%), heart block (three patients, 0.6%), and cardiac tamponade (one patient, 0.2%). 18, 28, 33, 39, 40, 48, 60, 61 Follow-up, recurrence of ventricular arrhythmia and mortality
The mean follow-up duration reported was 61 + 37 weeks (median 58, range 4-156). Ventricular arrhythmia recurred in 188 (40%, 95% CI: 27-47%) patients after the first procedure, while a recurrence after the last procedure occurred in 133 (28%, 95% CI: 17 -34%) patients. 17 Seventy-eight deaths (17%, 95% CI: 12-23%) were reported on the follow-up. 17,18,28,31 -33,39 -41,43 -49,51,55 -60,63 Most deaths were due to non-sudden cardiac causes (mostly progressive heart failure, 62%, 10% of overall population), while only a minority died due to intractable arrhythmia recurrence (23%, 4% of overall population). Non-cardiac mortality (stroke, pneumonia, cancer, and pancreatitis) was reported in 15%. No deaths occurred in patients with VF storm with NSHD, while 24% patients with VF or pVT storm and underlying heart disease died on the follow-up. Two studies did not separate deaths in VF or pVT storm patients. 18, 60 The time of death after the last procedure, reported in 23 publications with 77 deaths, ranged from first week to 90 weeks (median 12 weeks). The median time to death was ≤12 weeks in 55% of these patients.
Impact of incessant ventricular arrhythmia on procedural outcome, mortality, and ventricular arrhythmia recurrence 48 with 95 patients that detailed the HR and its 95% CI for predictors of cardiac mortality was also included. Other studies with less than five patients or not providing HR or OR with their 95% CI were excluded. None of the studies on VF storm ablation in NSHD provided these data.
35,36
The odds of death and VA recurrence did not appear to be associated with age or EF when pooled across the usable studies ( Table 4) . The pooled HR for the association between EF and time to cardiac death was 0.96, indicating that a one unit increase in EF was associated with a 4% reduction in the risk of cardiac death; however, the overall association was not statistically significant (95% CI: 0.92-1.00, P ¼ 0.067) (Figure 2) . The I-squared statistic was estimated to be 0.0%, indicating that the heterogeneity between studies did not exceed what would have been expected due to chance.
There was no difference in the odds of death (P ¼ 0.31) and VA recurrence (P ¼ 0.34) between the three disease groups of ICM, DCM, and ARVD + others ( Table 5) . Although the odds of death and recurrence were 49% (OR ¼ 0.51, 95% CI: 0.22 -1.22, P ¼ 0.13) and 35% (OR ¼ 0.65, 95% CI: 0.29 -1.43, P ¼ 0.28) lower in the ICM group relative to the DCM group, the difference between groups did not achieve statistical significance. Importantly, among studies with individual level data, 8 of 13 patients who had failed ablations belonged to the non-ICM groups suggesting higher failure rates in these groups.
The odds of VA recurrence were 3.8 times higher after ablation for arrhythmic storm of monomorphic VT relative to arrhythmic storm of VF or pVT with underlying cardiomyopathy (OR ¼ 3.76, 95% CI: 1.65-8.57, P ¼ 0.002); however, the odds of death did not differ between them (OR ¼ 0.69, 95% CI: 0.34-1.40,
Relationship between procedural outcome, mortality, and ventricular arrhythmia recurrence Ventricular arrhythmia recurrence and mortality data in relation to an individual procedural outcome was available from 38 studies (447 patients) and 37 studies (417 patients), respectively. Two studies 18, 56 did not provide these data. trophic cardiomyopathy, and sarcoidosis were included being high-risk subgroups for VA-related sudden cardiac death. 67 -69 As observed in this review, the frequency of these conditions was not as high as that of ICM or DCM which makes prospective randomized trials difficult to perform, and can possibly be evaluated only by exploring non-randomized observational studies in an alike method. Appraising available multi-centre studies, meta-analysis, and reviews
Most of the previously published data on VA storm ablation are single-centre small series or case reports, and there is relative small representation of VA storm patients in larger studies of VT ablation. The largest VT ablation study to-date, the multi-centre Thermocool VT ablation trial that included 231 recurrent VT patients with ICM-treated with catheter ablation, 14 had only 37
(16%) patients with incessant VT before ablation. In this cohort of incessant VT at 1-year following ablation, 49% had a recurrence of VT, 24% had recurrences of VT storm, and 11% died. Despite these sobering outcomes, the investigators concluded incessant VT to be a predictor of better primary outcome following ablation compared with those with intermittent VT (OR: 0.33, 95% CI: 0.13-0.86, P ¼ 0.02). However, since the description of primary endpoint was different for patients with incessant VT (recurrence of incessant VT) and intermittent VT (recurrence of any VT), the interpretation of this conclusion should be done cautiously. This paper was excluded from this systematic review as demographic and procedural outcome data of incessant VT were not reported separately. Other multi-centre studies, the Euro-VT study (14 out of 63 patients) 15 and epicardial VT ablation study (95 out of 218 patients), 26 were also not explicit in reporting demographics and outcomes in the patients with VA storm. In a recent meta-analysis of studies on VT catheter ablation as adjunct to medical therapy combining 457 patients, 71 where 20% of patient population were VA storm, the catheter ablation group showed only a trend towards reduction of arrhythmia in VA storm patients (P ¼ 0.06). The paper did not report the effect of VT ablation on survival for VA storm patients separately; however, overall there was no reduction in mortality. All the previously available reviews 18, 72, 73 had summarized the primary research with no attempt to extract and systematically analyse the data.
Major findings from the systematic review
The most important finding from this study is the high acute success rate of invasive management of VA storm, with 91% of patients having elimination of the clinical VA and 72% of patients having all inducible VA eliminated. Importantly, 94% patients were free from VA storm on follow-up, and arrhythmic sudden deaths were rare (4%). This is quite significant considering the lifethreatening status and cardiogenic shock present in many of these patients. It is, however, at the cost of multiple procedures (1.3 + 0.4 per patient), non-conventional modes of intervention such as ethanol ablation, sympathetic denervation, surgical ablation, and 23% patients requiring major invasive haemodynamic support during procedure. Despite these, the reported complication rate was fairly low (2%) and procedure-related deaths were only rare (,1%).
Palliation or mortality benefit
The largest study in the review by Carbucicchio et al. 48 that compared VA storm catheter ablation outcomes in stable patients with those presenting with haemodynamic instability showed a comparable acute success rate in both the groups. However, the latter had a greater number of recurrences and subsequent sudden deaths. This suggests that a proportion of patients with VA storm probably achieve only palliative benefit from the invasive intervention and their long-term outcomes remain poor. Overall, VA storm ablation appears to have a role beyond acute palliation and improves longterm outcomes. This is indicated by 17% all-cause mortality at 1.2 years of follow-up in our pooled database against comparable data on medically managed historic controls of VA storm who had 27% all-cause mortality at 1.6 years 8 and 38% at 3 years. 2 Further, if reduction in mortality is real, it is unclear whether this is secondary to reduction in arrhythmic or overall cardiac death. In this pooled analysis, arrhythmic sudden deaths accounted for 23% of deaths, while progressive heart failure accounted for 62%. This is compared with 25% unspecified deaths and 58% heart failure deaths in medically managed controls. 8 A key implication of this analysis is that all patients with VA storm are possibly suitable and should be offered ablation. However, even a successful procedure does not equate with even medium-term survival, as many of these patients still die of progressive heart failure. This entails that ablation alone is insufficient for some and perhaps high-arrhythmia frequency heralds preterminal pump failure with its own different set of possible interventions beyond purely anti-arrhythmic management.
Predictors of outcomes: mortality and ventricular arrhythmia recurrence Ejection fraction and underlying substrate There did not appear to be any significant predictors in baseline characteristics that indicate higher risk of death or arrhythmia recurrence on the follow-up. Only the EF appeared to have small inverse association with the secondary outcome of cardiac mortality, but it was not statistically significant. The possibility for this lack of importance of EF could be that, depending on when the measure for EF was made, it might include patients whose measures were temporarily depressed by arrhythmia frequency/ shocks as well as those whose function was permanently low, thus confounding the prognostic implication of very low systolic function. The odds of death following ablation were lowest for ICM compared with other forms of structural heart disease. This might be due in part to the predominantly endocardial location of VT isthmus sites in most ICM patients, when compared with a higher incidence of epicardial sites in DCM and ARVD. 74, 75 Studies by Carbucicchio et al. 48 Incessant ventricular arrhythmia Storm due to incessant VA predicted poor outcomes compared with arrhythmic storm of frequent VA. These patients had more than three times worse procedural outcomes and higher recurrence of any VA (42% increase), although there was no difference in sudden death. Incessant VA is likely to compound the haemodynamic instability as was reflected in many of these patients requiring multiple major support measures. Although not obvious in the studies, such patients generally have advanced disease and resistance to antiarrhythmic drugs, tolerate very narrow window for adequate mapping, and are more likely to have procedures done at off-hours, with limited auxiliary support, and shorter procedure times. All these elements could have perhaps produced the poor outcomes observed in these patients.
Monomorphic ventricular tachycardia vs. polymorphic ventricular tachycardia and ventricular fibrillation In our study, among patients with a form of cardiomyopathy, VA recurrence was significantly lower in the VF and pVT storm group compared with arrhythmic storm of monomorphic VT. This could be related to the differences in amount and composition of underlying scar in these patterns, with VF and pVT patients possibly having less confluent anatomic scarring with surviving Purkinje fibres compared with large confluent scarring often seen with monomorphic VT. 76, 77 Furthermore, VF storm with NSHD had dramatic reduction in VF episodes following ablation with only two isolated VA recurrences among 24 patients on the long-term follow up to 2 years. None of these patients died which was congruent with the fact that none had heart failure.
Failed procedure
Failure of the acute procedure presages high mortality on the follow-up. The leading study in the review from Carbucicchio et al. 48 reported high-cardiac mortality following failed catheter ablation (HR: 15.23, 95% CI: 2.05-112.83, P ¼ 0.008). In our study, the odds of death were four times higher in those with a failed procedure compared with those with a successful procedure. This potentially may be due to a pre-existing advanced stage of the disease and multiple VA or a detrimental effect of prolonged multiple failed procedures that contribute to the morbidity of heart failure and VA. Patients in whom ablation is failing are likely to have a greater number of ablation lesions with the potential of adversely affecting the ventricular function, although this hypothesis has not been proved in prior studies. 78 Importantly, in this study, 55% of the deaths that followed invasive intervention occurred in the first 3 months. This is much higher than medically managed VA storm patients where only 29% die in the first 3 months after its development. 2 Taken together, the findings provide a simple validation of the clinical impression that the majority of patients presenting with VA storm should undergo ablation as part of their overall management. The available data suggest that successful invasive intervention has a favourable impact on long-term outcomes; however, those who have failed procedures might have modest increase in death. None of the studies could address the question of which patient will benefit most from ablation. Given these important questions on the relative benefit of invasive VA storm management, it is worthwhile investigating long-term outcomes in VA storm population in a randomized controlled trial.
Study limitations
The most important limitation of this systematic review is all the studies were primarily observational small series and only a few studies were usable for meaningful survival and meta-analysis (12/39 studies; 240/471 patients). Notably, only 11 publications with more than five patients compiled individual level data and only one publication with study level data provided adequate predictor analysis data. It reduced the opportunity for a greater detailed analysis to explore the strength of effect association of different predictors on a recurrence of VA, all-cause morality and cardiac mortality. But the estimation of survival outcomes in relation with acute procedural result was more robust as data were available on 37 studies (417 patients). The lack of uniformity in assessing procedural result with 10 studies not including a formal VA inducibility testing at the end of the procedure cannot be rejected. The differences in the conduct of ablation present among these studies motivate the need of a standard practice that future studies on invasive management in VA storm should promptly follow. 79 Nonetheless, as our focus was not on the comparative outcome assessment of different substrates and strategies, the results demonstrate the effectiveness of ablation in VA storm and not as a guide to which patient will benefit from VA storm ablation. Owing to a lack of any randomized controlled trial data, it was impossible to compare and contrast medical therapy vs. intervention in these patients. The study cannot unequivocally advocate that ablation is superior to other therapies to enhance survival in patients with VA storm and further randomized controlled studies are needed to investigate this proposition. Although patients with NSHD, ARVD and other miscellaneous cardiac disorders were included, these conditions, whenever feasible, were dealt separately and their outcomes compared with the more common ICM and DCM. The bearing of the largest study from Carbucicchio et al. 48 outdoing in the results has to be conceded. Nevertheless, the method of systematic review and meta-analysis typically aggregates results from all data in the literature meeting inclusion criteria so as to facilitate rapid synthesis of adequately powered evidence and generation of new hypothesis. Data from 261 VA storm patients from 12 publications 12 -15,20 -27 were not included in the analysis, as it could not be separated from non-storm patients. These papers, though not explicitly on VA storm patients, possibly could have influenced the overall results and added important predictive information. Briefly, these discussed the use of irrigated ablation, 15 experience of epicardial ablation, 20,25 -27 ethanol ablation after failed catheter ablation, 13 ablation in biopsy proven viral myocarditis, 27 ablation in post-cardiac valve surgery, 24 the comparative usefulness of entrainment mapping vs. substrate mapping, 23 the need for early intervention, 12 palliative rather than curative role of ablation, 22 and 1-and 5-year outcomes of VA ablation in ICM. 14, 21 All these publications had commended the role of ablation in these patients. The pertinent issues of the advantage of entrainment mapping over substrate-based ablation and whether the epicardium should be accessed in all or selected patients with VA storm during the first procedure could not be resolved in this review.
The publication bias was minimized by including all the published reports irrespective of the ranking of the journal citations and excluding single-case reports.
Conclusion
Ventricular arrhythmia storm ablation has high-acute success rates, with a low rate of recurrent storms. It is a 'lifesaving' approach with acceptable efficacy and safety profile with a low complication rate and should be considered in patients not responsive to the available medical management. Heart failure is the dominant cause of death in the long term in patients having a successful procedure. Failure of the acute procedure carries a high mortality. 
